首頁 > 市場調查報告書 > 醫療設備

體外診斷

血液檢測市場規模、佔有率和成長分析：按檢測類型、最終用戶、技術、樣本類型和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2035610

血液檢測市場規模、佔有率和成長分析：按檢測類型、最終用戶、技術、樣本類型和地區分類－2026-2033年產業預測

Blood Testing Market Size, Share, and Growth Analysis, By Testing Type (Clinical Testing, Home Testing), By End User (Hospitals, Clinics), By Technology, By Sample Type, By Region - Industry Forecast 2026-2033

出版日期: 2026年05月04日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球血液檢測市場價值為 78 億美元，預計到 2033 年將從 2025 年的 83.4 億美元成長到 142.2 億美元，預測期（2026-2033 年）的複合年成長率為 6.9%。

受政府和私營部門醫療保健支出不斷成長的推動，全球血液檢測市場預計將顯著成長。國際醫療機構正積極推動創新技術，同時提高大眾對慢性病及其管理的認知。完善的法律規範促進了即時檢測（POC）的普及。慢性病盛行率的上升以及對健康評估工具需求的增加，預計將進一步推動市場成長。血液檢測在疾病監測中發揮著至關重要的作用，為產業相關人員創造了新的商機。糖尿病患者數量的急劇成長表明，患者總數將大幅增加，從而導致對可靠血液檢測解決方案的需求激增。監管機構也在積極推動有助於疾病早期發現的診斷測試的商業化。

全球血液檢測市場的成長要素

全球血液檢測市場成長的關鍵促進因素之一是大量外部資金湧入臨床研究領域，致力於開發創新先進的診斷技術。這些資金支持使研究人員和企業能夠探索和改進調查方法，最終實現更準確、更有效率的血液檢測。因此，這些技術進步不僅透過改善患者預後推動了市場擴張，而且還創造了競爭環境，鼓勵持續創新，並推動血液診斷領域新產品和解決方案的推出。

全球血液檢測市場的限制因素

全球血液檢測市場面臨許多挑戰，其中之一便是印度、印尼和馬來西亞等開發中國家的患者對先進技術的認知度普遍較低。這種認知不足阻礙了創新血液檢測方法的應用，進而限制了市場成長。這些地區的醫療衛生系統可能缺乏足夠的資源來向患者普及新技術，因此未能充分發揮提升診斷能力的潛力。因此，這些地區血液檢測市場的整體發展可能會受到阻礙，進而限制人們獲得高效、現代化的醫療解決方案。

全球血液檢測市場趨勢

隨著領導企業日益重視開發尖端解決方案以提升用戶體驗和診斷準確性，全球血液檢測市場正發生顯著變化，朝著創新和技術進步的方向發展。人工智慧 (AI) 和機器學習演算法的整合正在革新疾病早期檢測，使醫療服務提供者能夠提供及時且準確的檢測結果。此外，在以患者為中心的理念和對更便捷醫療服務的追求的推動下，對就地檢驗和居家檢測解決方案的需求也在不斷成長。這一趨勢標誌著人們致力於改進診斷方法，並最終改善全球患者的治療效果。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

LabCorp
Quest Diagnostics
Abbott Laboratories
BioReference Laboratories
Siemens Healthineers
Roche Diagnostics
Thermo Fisher Scientific
Becton, Dickinson and Company
PerkinElmer
Grifols
Ortho Clinical Diagnostics
DiaSorin
Hologic
Shionogi
EMD Millipore
Genomic Health
Cepheid
Illumina
Cypress Diagnostics
BioMerieux

結論與建議

簡介目錄

Product Code: SQMIG35A2519

Global Blood Testing Market size was valued at USD 7.8 Billion in 2024 and is poised to grow from USD 8.34 Billion in 2025 to USD 14.22 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global blood testing market is poised for significant growth driven by increased healthcare expenditure from both government and private sectors. International healthcare organizations are advancing innovative techniques while raising awareness about chronic diseases and their management. Constructive regulatory frameworks are enhancing the adoption of point-of-care (POC) testing. The rising prevalence of chronic illnesses, coupled with heightened demand for health assessment tools, is likely to propel market momentum. As blood testing plays a vital role in disease monitoring, new opportunities are emerging for industry players. With soaring diabetes statistics indicating a substantial rise in affected individuals, the demand for reliable blood testing solutions is expected to surge. Regulatory bodies are also facilitating the commercialization of diagnostic tests that support early disease detection.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Testing Market Segments Analysis

Global Blood Testing Market is segmented by Testing Type, End User, Technology, Sample Type and region. Based on Testing Type, the market is segmented into Clinical Testing and Home Testing. Based on End User, the market is segmented into Hospitals, Clinics and Individuals. Based on Technology, the market is segmented into Conventional Methods and Advanced Technologies. Based on Sample Type, the market is segmented into Blood and Other Bodily Fluids. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Testing Market

One of the key factors propelling the growth of the global blood testing market is the influx of external funding directed towards clinical studies focused on the development of innovative and advanced diagnostic technologies. This financial support enables researchers and companies to explore and enhance testing methodologies, ultimately leading to more accurate and efficient blood tests. As a result, the advancement of these technologies not only improves patient outcomes but also drives market expansion by fostering a competitive environment that encourages continuous innovation and the introduction of new products and solutions in the field of blood diagnostics.

Restraints in the Global Blood Testing Market

The Global Blood Testing market faces challenges due to a significant lack of awareness regarding advanced technological devices among patients in developing nations, including countries like India, Indonesia, and Malaysia. This limited understanding hampers the adoption of innovative blood testing methods, which in turn constrains market growth. As healthcare systems in these regions may not be fully equipped to educate patients about new technologies, the potential for improved diagnostic capabilities remains underutilized. Consequently, the overall development of the blood testing market in these regions could be stifled, limiting access to efficient and modern healthcare solutions.

Market Trends of the Global Blood Testing Market

The global blood testing market is experiencing a significant shift towards innovation and technological advancement, as key players increasingly prioritize the development of cutting-edge solutions to enhance user experience and diagnostic accuracy. The integration of Artificial Intelligence and machine learning algorithms is revolutionizing the early detection of diseases, enabling healthcare providers to deliver timely and precise results. Additionally, the demand for point-of-care testing and home-testing solutions is rising, driven by patient-centric approaches and the push for more accessible healthcare. This trend signifies a commitment to improving diagnostic practices and ultimately enhancing patient outcomes worldwide.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Blood Testing Market Size by Testing Type & CAGR (2026-2033)

Market Overview
Clinical Testing
- Routine Tests
- Complete Blood Count
- Metabolic Panel
- Diagnostics
- Infectious Disease Testing
- Genetic Testing
Home Testing
- Self-Testing Kits
- Mobile Testing Devices

Global Blood Testing Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
- Inpatient Services
- Outpatient Services
Clinics
- Private Practices
- Specialty Clinics
Individuals
- Health-Conscious Consumers
- Chronic Condition Patients

Global Blood Testing Market Size by Technology & CAGR (2026-2033)

Market Overview
Conventional Methods
- Phlebotomy
- Venipuncture Techniques
Advanced Technologies
- Point-of-Care Testing
- Lab-on-a-Chip

Global Blood Testing Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Blood
- Whole Blood
- Serum
Other Bodily Fluids
- Plasma
- Saliva Tests

Global Blood Testing Market Size & CAGR (2026-2033)

North America (Testing Type, End User, Technology, Sample Type)
- US
- Canada
Europe (Testing Type, End User, Technology, Sample Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Testing Type, End User, Technology, Sample Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Testing Type, End User, Technology, Sample Type)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Testing Type, End User, Technology, Sample Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

LabCorp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioReference Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shionogi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMD Millipore
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomic Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cypress Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments